ClinicalTrials.Veeva

Menu

Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT

Y

Yair Bar-Haim

Status

Unknown

Conditions

Anxiety Disorders

Treatments

Behavioral: Attention bias modification treatment (ABMT)
Behavioral: Attention Control Condition

Study type

Interventional

Funder types

Other

Identifiers

NCT02272959
loe140498ctil

Details and patient eligibility

About

First-line psychosocial treatments for anxiety disorders in children are largely exposure-based cognitive behavioral therapies (CBTs). Despite strong evidence supporting CBT's efficacy, for up to 50% of youth patients, symptoms of anxiety persist after a full course of treatment. What are the treatment options for these youth? Unfortunately, there is not a single empirical study in the youth anxiety treatment literature that has systematically examined treatment augmentation for youth who fail to respond to CBT. Empirical efforts to address this issue are important because youth who do not respond to CBT continue to suffer emotional distress and impairment associated with anxiety disorders. This study will address this gap via double-blind randomized controlled trial of Attention Bias Modification Treatment (ABMT) for anxious 10-18 year-olds who did not respond to standard CBT. Attention biases in threat processing have been assigned a prominent role in the etiology and maintenance of anxiety disorders. ABMT utilizes computer-based protocols to implicitly modify biased attentional patterns in anxious patients. Here, participants will be CBT non-responders who will be assessed by using clinical interviews and parent- and self-rated questionnaires before and after eight sessions of ABMT or placebo control, and again at an eight-week follow-up. We expect to see reduction in anxiety symptoms in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group. We also expect the findings to inform pathways to treatments for anxious children who do not respond to current standard first-line therapy, and to provide initial information on mechanisms of ABMT efficacy.

Enrollment

100 estimated patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

To be included all youth must:

  1. have received a full course of CBT and were deemed treatment non-responders.
  2. they must still have a primary diagnosis of GAD, SOP, or SAD.
  3. if they have comorbid attention deficit hyperactivity disorder (ADHD) or depressive disorders, it must be treated with medication and stable.
  4. if they have tics or impulse control problems, those problems must be treated with medication and stable and cause minimal or no impairment.

Exclusion Criteria: To be excluded youth must:

  1. meet diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation.
  2. show high likelihood of hurting themselves or others.
  3. have not been living with a primary caregiver who is legally able to give consent for the child's participation.
  4. be a victim of previously undisclosed abuse requiring investigation or ongoing supervision.
  5. be involved currently in another psychosocial treatment.
  6. have a serious vision problem that is not corrected with prescription lenses.
  7. have a physical disability that interferes with their ability to click a mouse button rapidly and repeatedly.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Attention Bias Modification treatment (ABMT)
Experimental group
Description:
Attention training via repeated trials of a dot-probe task intended to direct attention away from threat stimuli using threat and neutral stimuli.
Treatment:
Behavioral: Attention bias modification treatment (ABMT)
Placebo Group
Placebo Comparator group
Description:
Attention training via repeated trials of a dot-probe task not intended to change threat-related attention patterns using only neutral stimuli.
Treatment:
Behavioral: Attention Control Condition

Trial contacts and locations

1

Loading...

Central trial contact

Marian Linetzky, M.A.; Yair Bar-Haim, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems